Skip to content

Understanding Your Laboratory Test: A Patient Guide to Testing and Results

Published: August 9, 2026Updated: August 16, 2026

Beta galactosidase test measures the activity of an enzyme in dried blood spots to help diagnose certain genetic metabolic disorders.

Quick summary

{"Measures beta-galactosidase enzyme activity in blood","Used to screen for lysosomal storage diseases like GM1 gangliosidosis","Collected via a simple finger prick or heel stick as a dried blood spot","Abnormal results may indicate a genetic enzyme deficiency","Follow-up testing is needed to confirm diagnosis"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
55916-1
Short code
BGAL-DBS
Synonyms
B-Galactosidase DBS-cCnc
Category
chemistry
Sample
serum
Container
Dried blood spot (DBS) collection card - Whatman 903 filter paper or equivalent
Units
N/A
Ref low
1.5
Ref high
3
Fasting
false
Population
adult
Sex
all
Age range
0–999 years
Method
Fluorometric enzymatic assay
CPT
82542
SNOMED
395125005
Specimen volume
5-6 dried blood spot circles, each saturated with approximately 75-80 microliters of whole blood
Stability
Stable for up to 7 days at room temperature (15-25°C), up to 30 days at 2-8°C, and up to 1 year at -20°C or lower. Avoid exposure to direct sunlight and humidity.
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
72–336 hours
Order
routine

What is this test and what exactly does it measure in my body?

Beta galactosidase is an enzyme that helps break down certain sugars and fats in your body. This test measures how much of this enzyme is active in your blood. The sample is collected on a special filter paper as a dried blood spot (DBS), making it easy to collect, store, and transport.

Why is this test performed and when might my doctor recommend it for me?

This test is primarily used to screen for and help diagnose lysosomal storage disorders, particularly GM1 gangliosidosis and Morquio B disease. These are rare genetic conditions where the body lacks enough beta-galactosidase enzyme, leading to accumulation of harmful substances in cells. Early detection through newborn screening can allow for better management and treatment outcomes.

How is the sample collected and what can I expect during the collection process?

A small blood sample is obtained by pricking the finger (or heel in newborns) and placing drops of blood onto a special filter paper card. The blood dries on the paper and is then sent to a laboratory for testing. This method is simple, requires only a tiny amount of blood, and the sample can be stored at room temperature.

What do my test results mean and how will my doctor use them to guide my care?

Low or absent beta-galactosidase activity may indicate a deficiency, which could suggest GM1 gangliosidosis or Morquio B disease. Your healthcare provider will interpret the results in context with your symptoms, medical history, and other test results. Additional testing is usually needed to confirm a diagnosis.

Reference range

Reference ranges vary by laboratory; consult reference laboratory for specific values. Generally, normal beta-galactosidase activity in dried blood spots is reported as >/= 1.5-3.0 nmol/mL blood/hour depending on assay methodology.N/A

Specimen: serum

No special patient preparation required. For newborn screening, sample should be collected between 24-48 hours of life per standard heel stick protocol.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Beta galactosidase testing is important for diagnosing GM1 gangliosidosis, a rare neurodegenerative disorder that affects motor skills, vision, and cognitive development. It is also used to diagnose Morquio B disease, which affects bone development and can cause short stature and skeletal abnormalities. Newborn screening programs may include this test to identify affected infants before symptoms appear, enabling early intervention and treatment.

Frequently asked questions

Is this test painful?
The test involves a small finger prick or heel stick, which may cause brief discomfort similar to a tiny pinprick. The dried blood spot method is less invasive than traditional blood draws.
How long does it take to get results?
Results typically take a few days to a week, depending on the laboratory. Your healthcare provider will contact you with the results.
What happens if my baby's test is abnormal?
An abnormal result does not necessarily mean your baby has the condition. The screening test is preliminary, and follow-up diagnostic testing will be arranged to confirm or rule out the diagnosis. Early detection allows for better management and support.
Can adults have this test?
Yes, this test can be performed at any age if a lysosomal storage disease is suspected based on symptoms such as developmental delays, movement problems, or skeletal abnormalities.
Is treatment available?
While there is no cure for these conditions, management includes supportive care, physical therapy, and in some cases, enzyme replacement therapy. Early intervention can help improve quality of life and manage symptoms.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy